Showing results (401-410 of 2,330) with videos related to
Sort By:
Pageof 233
Clinical Drug Investigation|January 19, 2020
Factors Influencing Placebo Responses in Rheumatoid Arthritis Clinical Trials: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled StudiesKota Nagai, Keisuke Matsubayashi, Kazuki Ide, et al.Clinical Drug Investigation|August 22, 2015
Effect of food on the pharmacokinetics of piperaquine and dihydroartemisininStephanie E Reuter, Allan M Evans, Sepehr Shakib, et al.Clinical Drug Investigation|August 22, 2015
Higher risk of sulfonylurea-associated hypoglycemic symptoms in women with type 2 diabetes mellitusAyami Kajiwara, Ayana Kita, Junji Saruwatari, et al.Clinical Drug Investigation|August 22, 2015
Interactions between CYP3A5*3 and POR*28 polymorphisms and lipid lowering response with atorvastatinKan-kan Wei, Li-rong ZhangClinical Drug Investigation|October 28, 2017
Prevalence of Use and Cost of Biological and Non-Biological Targeted Therapies for Cancer Treatment: A 5-Year Picture from Southern ItalySimona Lucchesi, Ilaria Marcianò, Paolo Panagia, et al.Clinical Drug Investigation|August 25, 2017
Lactate Levels with Chronic Metformin Use: A Narrative ReviewWeiyi Huang, Ronald L Castelino, Gregory M PetersonClinical Drug Investigation|May 23, 2022
Cost-Effectiveness Analysis of Atezolizumab Versus Durvalumab as First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer in the USAYelena Ionova, Wilson Vuong, Omar Sandoval, et al.Clinical Drug Investigation|May 10, 2022
Management of Hepatic Encephalopathy Associated with Advanced Liver DiseaseRita García-Martínez, Raquel Diaz-Ruiz, Marta PoncelaClinical Drug Investigation|January 8, 2021
Prevalence and Significance of Potential Pharmacokinetic Drug-Drug Interactions Among Patients with Lung Cancer: Implications for Clinical TrialsSawsan Rashdan, Hui Yang, Tri Le, et al.Clinical Drug Investigation|January 27, 2020
Comparison of the Effects of Secukinumab and Adalimumab Biosimilar on Radiographic Progression in Patients with Ankylosing Spondylitis: Design of a Randomized, Phase IIIb Study (SURPASS)Xenofon Baraliakos, Mikkel Østergaard, Lianne S Gensler, et al.Pageof 233